FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304014200> ?p ?o ?g. }

• W4304014200 abstract "Rating lymphocytes (TILs) are a prognostic marker in breast cancer and high TIL infiltration correlates with better patient outcomes. Meanwhile, parameters involving immune cells in peripheral blood have also been established as prognostic markers. High platelet-to-lymphocyte ratios (PLRs) and neutrophil-to-lymphocyte ratios (NLRs) are related to poor outcomes in breast cancer, but their mechanisms remain unknown. To date, TILs and these parameters have been examined separately.We investigated the relationship between TILs and the peripheral blood markers, PLR and NLR, in the same patients, using surgical specimens from 502 patients with invasive breast carcinoma without preoperative chemotherapy. For analysis of triple-negative breast cancer (TNBC) patient outcomes, 59 patients who received preoperative chemotherapy were also examined. For immune cell profiling, multiplexed fluorescent immunohistochemistry (mfIHC) of CD3, CD4, CD8, FOXP3 and T-bet, was conducted.A positive correlation between PLR and TIL was observed in TNBC (P = 0.013). On mfIHC, tumors in patients with high PLR and NLR contained more CD3+CD4+FOXP3+ T-cells (P = 0.049 and 0.019, respectively), while no trend was observed in CD8+ T-cells. TNBC patients had different patterns of outcomes according to TIL and PLR, with the TIL-high/PLR-low group having the lowest rate of disease relapse and death, and the longest distant metastasis-free and overall survivals, while the TIL-low/PLR-high group had the shortest survivals.Our data suggest that the combination of PLR with TIL assessment may enable more accurate prediction of patient outcomes with TNBC." @default.
• W4304014200 created "2022-10-10" @default.
• W4304014200 creator A5010476683 @default.
• W4304014200 creator A5015229603 @default.
• W4304014200 creator A5025940379 @default.
• W4304014200 creator A5027178556 @default.
• W4304014200 creator A5036684310 @default.
• W4304014200 creator A5049121810 @default.
• W4304014200 creator A5051370975 @default.
• W4304014200 creator A5066742789 @default.
• W4304014200 creator A5067415902 @default.
• W4304014200 creator A5067576408 @default.
• W4304014200 creator A5074632449 @default.
• W4304014200 creator A5077340312 @default.
• W4304014200 creator A5079304437 @default.
• W4304014200 creator A5080959979 @default.
• W4304014200 creator A5085872090 @default.
• W4304014200 creator A5087541425 @default.
• W4304014200 date "2022-10-10" @default.
• W4304014200 modified "2023-10-11" @default.
• W4304014200 title "High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs" @default.
• W4304014200 cites W1502181242 @default.
• W4304014200 cites W1586470106 @default.
• W4304014200 cites W1841839849 @default.
• W4304014200 cites W1870300447 @default.
• W4304014200 cites W1966556597 @default.
• W4304014200 cites W1982453726 @default.
• W4304014200 cites W2028415685 @default.
• W4304014200 cites W2032651612 @default.
• W4304014200 cites W2094095317 @default.
• W4304014200 cites W2098683355 @default.
• W4304014200 cites W2107989579 @default.
• W4304014200 cites W2120431466 @default.
• W4304014200 cites W2127810076 @default.
• W4304014200 cites W2136404658 @default.
• W4304014200 cites W2148237316 @default.
• W4304014200 cites W2396716940 @default.
• W4304014200 cites W2560367415 @default.
• W4304014200 cites W2571423414 @default.
• W4304014200 cites W2746363445 @default.
• W4304014200 cites W2751382700 @default.
• W4304014200 cites W2771978163 @default.
• W4304014200 cites W2892951532 @default.
• W4304014200 cites W2897279146 @default.
• W4304014200 cites W2897422388 @default.
• W4304014200 cites W2955071389 @default.
• W4304014200 cites W3007081516 @default.
• W4304014200 cites W3014346486 @default.
• W4304014200 cites W3026259888 @default.
• W4304014200 cites W3077251618 @default.
• W4304014200 cites W3091444396 @default.
• W4304014200 cites W3109853980 @default.
• W4304014200 cites W3127482120 @default.
• W4304014200 cites W3148045954 @default.
• W4304014200 cites W3191601662 @default.
• W4304014200 cites W3208320839 @default.
• W4304014200 cites W4206167389 @default.
• W4304014200 doi "https://doi.org/10.1186/s13058-022-01563-7" @default.
• W4304014200 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36217150" @default.
• W4304014200 hasPublicationYear "2022" @default.
• W4304014200 type Work @default.
• W4304014200 citedByCount "9" @default.
• W4304014200 countsByYear W43040142002023 @default.
• W4304014200 crossrefType "journal-article" @default.
• W4304014200 hasAuthorship W4304014200A5010476683 @default.
• W4304014200 hasAuthorship W4304014200A5015229603 @default.
• W4304014200 hasAuthorship W4304014200A5025940379 @default.
• W4304014200 hasAuthorship W4304014200A5027178556 @default.
• W4304014200 hasAuthorship W4304014200A5036684310 @default.
• W4304014200 hasAuthorship W4304014200A5049121810 @default.
• W4304014200 hasAuthorship W4304014200A5051370975 @default.
• W4304014200 hasAuthorship W4304014200A5066742789 @default.
• W4304014200 hasAuthorship W4304014200A5067415902 @default.
• W4304014200 hasAuthorship W4304014200A5067576408 @default.
• W4304014200 hasAuthorship W4304014200A5074632449 @default.
• W4304014200 hasAuthorship W4304014200A5077340312 @default.
• W4304014200 hasAuthorship W4304014200A5079304437 @default.
• W4304014200 hasAuthorship W4304014200A5080959979 @default.
• W4304014200 hasAuthorship W4304014200A5085872090 @default.
• W4304014200 hasAuthorship W4304014200A5087541425 @default.
• W4304014200 hasBestOaLocation W43040142001 @default.
• W4304014200 hasConcept C121608353 @default.
• W4304014200 hasConcept C126322002 @default.
• W4304014200 hasConcept C143998085 @default.
• W4304014200 hasConcept C167672396 @default.
• W4304014200 hasConcept C203014093 @default.
• W4304014200 hasConcept C2777761686 @default.
• W4304014200 hasConcept C2778326572 @default.
• W4304014200 hasConcept C2779727006 @default.
• W4304014200 hasConcept C2780110267 @default.
• W4304014200 hasConcept C2780140570 @default.
• W4304014200 hasConcept C530470458 @default.
• W4304014200 hasConcept C71924100 @default.
• W4304014200 hasConcept C8891405 @default.
• W4304014200 hasConceptScore W4304014200C121608353 @default.
• W4304014200 hasConceptScore W4304014200C126322002 @default.
• W4304014200 hasConceptScore W4304014200C143998085 @default.
• W4304014200 hasConceptScore W4304014200C167672396 @default.
• W4304014200 hasConceptScore W4304014200C203014093 @default.
• W4304014200 hasConceptScore W4304014200C2777761686 @default.

• next